Literature DB >> 11776405

Dexamethasone inhibits apoptosis of eosinophils isolated from hypereosinophilic patients.

F Debierre-Grockiego1, I Leduc, L Prin, V Gouilleux-Gruart.   

Abstract

Glucocorticoids reduce in vivo the number of eosinophils and are effective in treatment of blood and tissue hypereosinophilia. Dexamethasone is a synthetic glucocorticoid known to induce in vitro apoptosis of eosinophils of healthy donors, and apoptosis may be a mechanism induced by glucocorticoids to reduce eosinophilia. Here we confirm that dexamethasone exerts a pro-apoptotic effect on eosinophils isolated from healthy subjects but that dexamethasone is not always a pro-apoptotic agent towards eosinophils from hypereosinophilic patients. Implications of these results in the resistance of some patients to a treatment by glucocorticoids are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11776405     DOI: 10.1078/0171-2985-00060

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  2 in total

1.  Hypereosinophilic Syndrome Subtype Predicts Responsiveness to Glucocorticoids.

Authors:  Paneez Khoury; Annalise O Abiodun; Nicole Holland-Thomas; Michael P Fay; Amy D Klion
Journal:  J Allergy Clin Immunol Pract       Date:  2017-07-27

Review 2.  Transcription Factors in Eosinophil Development and As Therapeutic Targets.

Authors:  Patricia C Fulkerson
Journal:  Front Med (Lausanne)       Date:  2017-07-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.